Company & Sponsor Intelligence

Medical University of South Carolina

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials23

Recruiting6

Completed15

Countries1

Therapeutic footprint

adhdalzheimersautismdepressionepilepsyother_neurologyother_psychiatrypain_neuropathyparkinsonsptsdstrokesubstance_use

Indexed studies

NCT02723175The Effects of CBT and tDCS on Fibromyalgia Patients
pain_neuropathy · United StatesNA

NCT03732248Altering Memories That Increase Risk of Relapse in Alcohol Use Disorders
substance_use · United StatesPHASE1

NCT02998684Learning Enhancement Through Neurostimulation in Autism
autism · United StatesNA

NCT07226011Accelerated High-Dose tDCS for Depression
depression · United StatesNA

NCT06748209Establishing Mobile Transcranial Magnetic Stimulation
depression · United StatesPHASE4

NCT01573273Oxytocin in Cocaine Dependence
substance_use · United StatesNA

NCT07084792Dynamic Motor Cortical Responses to Subdural Electrical Stimulation.
parkinsons · NA

NCT03273270Effects of Neuromodulation and Rehabilitation of the Locomotor Network in Freezing of Gait
parkinsons · United StatesNA

NCT03622814Partners at Meals - Respite Care and Home (PAM)
alzheimers · United StatesNA

NCT05855369Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
other_neurology · United StatesPHASE2, PHASE3

NCT06698328fMRI Tracking taVNS in ASD
autism · United StatesNA

NCT00844701Cue Induced Imaging in Nicotine Dependent Smokers
other_psychiatry · United StatesCOMPLETED

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →